Related Experiment Video
Updated: Jun 4, 2025
Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells
Published on: April 4, 2016
Modern biology of extrachromosomal DNA: A decade-long voyage of discovery
Qing-Lin Yang1,2, Yipeng Xie1, Kailiang Qiao1
1Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract:
Genomic instability is a hallmark of cancer and is a major driving force of tumorigenesis. A key manifestation of genomic instability is the formation of extrachromosomal DNAs (ecDNAs) - acentric, circular DNA molecules ranging from 50 kb to 5 Mb in size, distinct from chromosomes. Ontological studies have revealed that ecDNA serves as a carrier of oncogenes, immunoregulatory genes, and enhancers, capable of driving elevated transcription of its cargo genes and cancer heterogeneity, leading to rapid tumor evolution and therapy resistance. Although ecDNA was documented over half a century ago, the past decade has witnessed a surge in breakthrough discoveries about its biological functions. Here, we systematically review the modern biology of ecDNA uncovered over the last ten years, focusing on how discoveries during this pioneering stage have illuminated our understanding of ecDNA-driven transcription, heterogeneity, and cancer progression. Furthermore, we discuss ongoing efforts to target ecDNA as a novel approach to cancer therapy. This burgeoning field is entering a new phase, poised to reshape our knowledge of cancer biology and therapeutic strategies.
Insights
Extrachromosomal DNAs (ecDNAs) drive cancer progression and therapy resistance by carrying oncogenes. Recent research highlights their role in cancer biology and explores targeting ecDNA for novel cancer treatments.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Genomic instability is a key driver of cancer development.
- Extrachromosomal DNAs (ecDNAs) are circular DNA molecules that manifest genomic instability.
- ecDNAs carry oncogenes and enhancers, promoting tumor evolution and treatment resistance.
Purpose of the Study:
- To systematically review recent breakthroughs in understanding ecDNA biology.
- To elucidate the role of ecDNA in cancer progression and heterogeneity.
- To discuss novel therapeutic strategies targeting ecDNA.
Main Methods:
- Systematic literature review of studies from the past decade.
- Analysis of ontological data on ecDNA content.
- Review of emerging therapeutic approaches targeting ecDNA.
Main Results:
- Recent discoveries have significantly advanced the understanding of ecDNA-driven transcription.
- ecDNAs contribute to cancer heterogeneity and rapid tumor evolution.
- Targeting ecDNA presents a promising new avenue for cancer therapy.
Conclusions:
- The last decade has revealed critical insights into the biological functions of ecDNA.
- ecDNA plays a pivotal role in tumorigenesis and therapeutic resistance.
- Targeting ecDNA is poised to revolutionize cancer biology and treatment strategies.
Related Concept Videos
03:21Genome Size and the Evolution of New Genes
00:58Genomic DNA in Eukaryotes
02:32Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
01:51Lampbrush Chromosomes
LBCs are made up of two pairs of conjugating homologous chromatids. Each chromatid consists of alternatively positioned regions of condensed-inactive chromatin and loosely placed-active side loops, which can be contracted and extended. The loops...
02:13Overview of Transposition and Recombination
03:01The Replisome
The synthesis of the leading and lagging strands is a highly coordinated process. To explain this, the “Trombone model” was proposed by Bruce Alberts in 1980. The DNA loop formation starts when a primer is synthesized on the parent lagging strand. The loop grows with...